Linzess is a brand-name medication prescribed for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It is a guanylate cyclase-C (GC-C) agonist that works by increasing fluid secretion in the intestines and speeding up the passage of stool [1].
When will Linzess lose its patent protection?
The patent protection for Linzess is set to expire in 2026 [2]. This timeline indicates when generic versions of the drug may become available.
What are the generic alternatives for Linzess?
Currently, there are no generic versions of Linzess available in the market. The active ingredient in Linzess is linaclotide [1]. While the patent is expected to expire in 2026, the development and approval process for generics can be complex and take time.
What is the active ingredient in Linzess?
The active ingredient in Linzess is linaclotide [1]. It is this compound that is responsible for the medication's therapeutic effects.
How do GC-C agonists work?
Guanylate cyclase-C (GC-C) agonists, like linaclotide, work by activating receptors in the intestinal lining. This activation stimulates the secretion of chloride and bicarbonate into the intestinal lumen. The increased fluid in the intestines helps to soften the stool and promote its movement through the digestive tract, thereby relieving constipation [1].
What are the side effects of Linzess?
The most common side effect reported with Linzess is diarrhea [1]. Other potential side effects can include abdominal pain, bloating, and gas. Patients experiencing severe or persistent diarrhea should contact their healthcare provider.
Can the price of Linzess change when generics become available?
Generally, when generic versions of a drug become available, the competition drives down the price. This means that once a generic for Linzess is approved and marketed, the cost of treatment is likely to decrease significantly compared to the brand-name drug [2].
Are there other medications for IBS-C and CIC?
Yes, there are other medications available for treating IBS-C and CIC. These include other GC-C agonists, secretagogues, and medications that affect gut motility or sensitivity [3]. Your healthcare provider can discuss the best treatment options based on your specific condition and medical history.
Who manufactures Linzess?
Linzess is manufactured by Ironwood Pharmaceuticals and AbbVie [1].
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com